187 related articles for article (PubMed ID: 28858203)
1. Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.
Bahls L; Yamakawa R; Zanão K; Alfieri D; Flauzino T; Delongui F; de Abreu A; Souza R; Gimenes F; Reiche E; Borelli S; Consolaro M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858203
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
[TBL] [Abstract][Full Text] [Related]
4. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
8. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
9. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.
Mahmud SM; Robinson K; Richardson H; Tellier PP; Ferenczy AS; Roger M; Coutlee F; Franco EL
J Infect Dis; 2007 Jul; 196(1):82-90. PubMed ID: 17538887
[TBL] [Abstract][Full Text] [Related]
10. Association of human leukocyte antigen and T cell message with human papillomavirus 16-positive cervical neoplasia in Japanese women.
Saito M; Okubo M; Hirata R; Takeda S; Maeda H
Int J Gynecol Cancer; 2007; 17(6):1314-21. PubMed ID: 17433060
[TBL] [Abstract][Full Text] [Related]
11. A risk evaluation model of cervical cancer based on etiology and human leukocyte antigen allele susceptibility.
Hu B; Tao N; Zeng F; Zhao M; Qiu L; Chen W; Tan Y; Wei Y; Wu X; Wu X
Int J Infect Dis; 2014 Nov; 28():8-12. PubMed ID: 25223804
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA-A, -B, DRB, and DQB Alleles with Persistent HPV-16 Infection in Women from Tamil Nadu, India.
Bhaskaran M; Murali SV; Rajaram B; Krishnasamy S; Devasena CS; Pathak A; Ravi V; Swaminathan K; Ayyappa A; Vedhantham S; Seshachalam A; ArunKumar G
Viral Immunol; 2019 Dec; 32(10):430-441. PubMed ID: 31800372
[TBL] [Abstract][Full Text] [Related]
13. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus.
Simões RT; Gonçalves MA; Castelli EC; Júnior CM; Bettini JS; Discorde ML; Duarte G; Quintana SM; Simões AL; Moreau P; Carosella ED; Soares EG; Donadi EA
Mod Pathol; 2009 Aug; 22(8):1075-82. PubMed ID: 19407850
[TBL] [Abstract][Full Text] [Related]
14. Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.
Adebamowo SN; Adeyemo AA;
Hum Immunol; 2019 Sep; 80(9):723-730. PubMed ID: 31072753
[TBL] [Abstract][Full Text] [Related]
15. From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity.
Paaso A; Jaakola A; Syrjänen S; Louvanto K
Acta Cytol; 2019; 63(2):148-158. PubMed ID: 30783048
[TBL] [Abstract][Full Text] [Related]
16. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.
de Araujo Souza PS; Maciag PC; Ribeiro KB; Petzl-Erler ML; Franco EL; Villa LL
BMC Cancer; 2008 Aug; 8():246. PubMed ID: 18721466
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
18. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.
Beskow AH; Gyllensten UB
Int J Cancer; 2002 Oct; 101(6):526-31. PubMed ID: 12237892
[TBL] [Abstract][Full Text] [Related]
19. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
[TBL] [Abstract][Full Text] [Related]
20. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
